NEUROCRINE Trademark

Trademark Overview


On Thursday, September 21, 2023, a trademark application was filed for NEUROCRINE with the United States Patent and Trademark Office. The USPTO has given the NEUROCRINE trademark a serial number of 98975517. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Saturday, January 18, 2025. This trademark is owned by Neurocrine Biosciences, Inc.. The NEUROCRINE trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for human use for the treatment of Huntington's Disease, chorea associated with Huntington's Disease

Providing medical information; Providing medical information in the field of endocrine, hormonal, and genetic diseases, disorders, and conditions; providing medical information in the field of psychiatric, neurological, central nervous system, and movement diseases, disorders, and conditions; Providing medical information in the field of Huntington's Disease and chorea associated with Huntington's Disease
neurocrine

General Information


Serial Number98975517
Word MarkNEUROCRINE
Filing DateThursday, September 21, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateSaturday, January 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use for the treatment of Huntington's Disease, chorea associated with Huntington's Disease
Goods and ServicesProviding medical information; Providing medical information in the field of endocrine, hormonal, and genetic diseases, disorders, and conditions; providing medical information in the field of psychiatric, neurological, central nervous system, and movement diseases, disorders, and conditions; Providing medical information in the field of Huntington's Disease and chorea associated with Huntington's Disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, October 8, 2023
Primary Code005
First Use Anywhere DateThursday, February 1, 2024
First Use In Commerce DateThursday, February 1, 2024

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, October 8, 2023
Primary Code044
First Use Anywhere DateFriday, April 15, 2016
First Use In Commerce DateFriday, April 15, 2016

Trademark Owner History


Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Monday, September 25, 2023NEW APPLICATION ENTERED
Sunday, October 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 15, 2024ASSIGNED TO EXAMINER
Thursday, May 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 29, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 18, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 18, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 23, 2024SOU TEAS EXTENSION RECEIVED
Friday, August 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 23, 2024SOU EXTENSION 1 GRANTED
Friday, August 23, 2024SOU EXTENSION 1 FILED
Tuesday, September 24, 2024DIVISIONAL REQUEST RECEIVED
Tuesday, September 24, 2024USE AMENDMENT FILED
Tuesday, September 24, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, September 24, 2024TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, December 4, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 9, 2024ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Friday, December 20, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 17, 2025DIVISIONAL PROCESSING COMPLETE
Friday, January 17, 2025STATEMENT OF USE PROCESSING COMPLETE
Saturday, January 18, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, January 18, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED